You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

leukapheresis

Showing 1 - 25 of 906
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Leukapheresis Procedures to Obtain Plasma and Lymphocytes for

Recruiting
  • HIV
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 7, 2023

    Cancer, Immune System or Toxicities Suspected Trial in Paris, Saint-Cloud (blood sample)

    Recruiting
    • Cancer
    • Immune System or Toxicities Suspected
    • blood sample
    • Paris, France
    • +1 more
    Sep 16, 2022

    Ulcerative Colitis (UC) Trial in Stockholm (TLA Gut™)

    Recruiting
    • Ulcerative Colitis (UC)
    • TLA Gut™
    • Stockholm, Sweden
      Ersta Sjukhus, Medicinkliniken
    Nov 7, 2022

    Leukapheresis to Obtain Plasma or Lymphocytes for Studies of

    Recruiting
    • HIV
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 13, 2023

      Manufacture of Clinical T-cell Products for Future Treatment

      Completed
      • Virus-specific T Cells
      • Leukapheresis
      • Basel, Switzerland
        University Hospital Basel, Departement Infektiologie & Spitalhyg
      Feb 3, 2023

      Stem Cells Mobilization, colLection and Engraftment in Newly

      Recruiting
      • Multiple Myeloma
      • +3 more
      • Rome, Italy
        Fondazione Policlinico Universitario A.Gemelli IRCCS
      Apr 28, 2023

      Liver Transplant Trial in Boston (biological, procedure, drug)

      Recruiting
      • Liver Transplant
      • arTreg-CSB
      • +4 more
      • Boston, Massachusetts
        Massachusetts General Hospital: Transplantation
      Jan 30, 2023

      Large B-cell Lymphoma, B-cell Lymphoma Trial in Houston (Magrolimab, Rituximab, CAR T leukapheresis)

      Not yet recruiting
      • Large B-cell Lymphoma
      • B-cell Lymphoma
      • Houston, Texas
        M D Anderson Cancer Center
      Jun 29, 2023

      Lymphomas, B-cell Lymphomas Trial in Houston (JV-213, Leukapheresis)

      Not yet recruiting
      • Lymphomas
      • B-cell Lymphomas
      • Houston, Texas
        The University of Texas M D Anderson Cancer Center
      Mar 6, 2023

      Improved Methods of Cell Selection for Bone Marrow Transplant

      Recruiting
      • Graft-Versus-Host Disease
      • +2 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 23, 2023

      Malignant Glioma, Glioblastoma Multiforme, Anaplastic Astrocytoma Trial in Miami (biological, drug, procedure)

      Completed
      • Malignant Glioma
      • +3 more
      • Dendritic Cell Vaccine
      • +3 more
      • Miami, Florida
        University of Miami
      Jul 19, 2022

      Solid Tumor Trial in Houston (Single Injection of IVS-3001- Anti - HLA-G CAR-T cells, Fludarabine phosphate, Cyclophosphamide)

      Not yet recruiting
      • Solid Tumor
      • Single Injection of IVS-3001- Anti - HLA-G CAR-T cells
      • +3 more
      • Houston, Texas
        M D Anderson Cancer Center
      Jan 19, 2023

      Acute Myeloid Leukemia Trial in Saint Louis (Graft cell infusion, Tacrolimus, Mycophenolate mofetil)

      Recruiting
      • Acute Myeloid Leukemia
      • Graft cell infusion
      • +6 more
      • Saint Louis, Missouri
        Washington University School of Medicine
      Jan 29, 2023

      Liver Transplant Trial in San Francisco (biological, procedure, drug)

      Recruiting
      • Liver Transplant
      • arTreg
      • +4 more
      • San Francisco, California
        University of California, San Francisco
      Sep 13, 2022

      Sickle Cell Disease Trial in Saint Louis (Motixafortide, Natalizumab, Leukapheresis)

      Not yet recruiting
      • Sickle Cell Disease
      • Saint Louis, Missouri
        Washington University School of Medicine
      Nov 8, 2022

      T-cell Non-Hodgkin Lymphoma Trial in Boston (Cyclophosphamide, Doxorubicin, Vincristine)

      Terminated
      Has Results
      • T-cell Non-Hodgkin Lymphoma
      • Boston, Massachusetts
      • +1 more
      Jan 26, 2023

      Relapsed Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia, MDS Trial (biological, drug, procedure)

      Withdrawn
      • Relapsed Acute Myeloid Leukemia
      • +2 more
      • Cytokine-induced memory-like NK cells
      • +4 more
      • (no location specified)
      Feb 23, 2022

      Primary Mediastinal Large B-cell Lymphoma (PMBCL), Primary Mediastinal Large B Cell Lymphoma, Primary Mediastinal Large B-Cell

      Not yet recruiting
      • Primary Mediastinal Large B-cell Lymphoma (PMBCL)
      • +5 more
      • Boston, Massachusetts
      • +1 more
      Jun 28, 2023

      Metastatic Hormone-Sensitive Prostate Cancer Trial in Saint Louis (biological, drug, device, procedure)

      Completed
      • Metastatic Hormone-Sensitive Prostate Cancer
      • PROSTVAC-V
      • +9 more
      • Saint Louis, Missouri
        Washington University School of Medicine
      Aug 3, 2022

      The Use of Leukapheresis to Support HIV Pathogenesis Studies

      Recruiting
      • HIV
      • Leukapheresis
      • San Francisco, California
        San Francisco General Hospital
      Dec 15, 2020

      Crohn Disease Trial in Los Angeles (drug, procedure, biological)

      Recruiting
      • Crohn Disease
      • Los Angeles, California
        Cedars-Sinai Medical Center
      Mar 23, 2022

      Refractory Acute Myeloid Leukemia, Relapsed Acute Myeloid Leukemia Trial in Saint Louis (biological, drug, procedure)

      Not yet recruiting
      • Refractory Acute Myeloid Leukemia
      • Relapsed Acute Myeloid Leukemia
      • Cytokine induced memory-like NK cells
      • +5 more
      • Saint Louis, Missouri
        Washington University School of Medicine
      Jun 30, 2022

      Multiple Myeloma Trial in Westwood (Bortezomib, Granulocyte colony-stimulating factor (G-CSF), Mozobil)

      Completed
      Has Results
      • Multiple Myeloma
      • Westwood, Kansas
        The University of Kansas Medical Center
      May 24, 2021

      Acute Lymphoblastic Leukemia, in Relapse, Acute Lymphoblastic Leukemia, Refractory, Pediatric ALL Trial in Memphis (biological,

      Recruiting
      • Acute Lymphoblastic Leukemia, in Relapse
      • +2 more
      • CD19-CAR(Mem) T-cells
      • +5 more
      • Memphis, Tennessee
        St. Jude Children's Research Hospital
      Aug 5, 2022

      Stage III Cutaneous Melanoma AJCC v7, Stage IIIA Cutaneous Melanoma AJCC v7, Stage IIIB Cutaneous Melanoma AJCC v7 Trial in

      Active, not recruiting
      • Stage III Cutaneous Melanoma AJCC v7
      • +4 more
      • Cryosurgery
      • +3 more
      • Rochester, Minnesota
        Mayo Clinic
      Jan 3, 2023